Skip to content
Clinical Trials – home

Groupe Hospitalier du Havre - Hôpital Jacques Monod

Verifiedinfo

France 55 B Rue Gustave Flaubert, Bp 24, 76083 Montivilliers, France

  • 12 trials recruiting
  • Plasma cell myeloma · Chronic obstructive pulmonary disease · Rheumatoid arthritis
  • Adults and children

About Specializations

Groupe Hospitalier du Havre - Hôpital Jacques Monod in Montivilliers, France specialises in clinical trials of conditions such as Plasma cell myeloma, Chronic obstructive pulmonary disease, Rheumatoid arthritis, Asthma, and other specialisations. This site conducts important research.

Main research areas of the site

Hematology and Oncology

The medical center is at the forefront of hematology and oncology, with a particular focus on Multiple Myeloma. The institution is dedicated to advancing treatment options for elderly patients who are newly diagnosed and ineligible for transplant.

  • Multiple Myeloma in Elderly Patients
  • Non-Frail Transplant Ineligible Populations
  • Innovative Combination Therapies

Through its research, the center is contributing to the development of novel therapeutic strategies, enhancing the quality of life and treatment outcomes for patients with complex hematological conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
55 B Rue Gustave Flaubert, Bp 2476083 MontivilliersFrance
Recruiting now
12 trials
Conditions studied
18
Partner status
Verified

More sites in MontivilliersFrance

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

27 clinical trials

Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Depemokimab
  • Sponsor:Glaxosmithkline Research & Development Limited
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Ambrisentan
  • Sponsor:Assistance Publique Hopitaux De Paris
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Bortezomib
  • Sponsor:Intergroupe Francophone Du Myelome
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Rituximab
  • Sponsor:Les Hopitaux Universitaires De Strasbourg
Countries:FranceFrance
  • Participants:65+ years
  • Substances:Clopidogrel
  • Sponsor:Centre Hospitalier Universitaire De Caen Normandie
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Dexamethasone
  • Sponsor:Assistance Publique Hopitaux De Paris
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Omalizumab
  • Sponsor:Assistance Publique Hopitaux De Paris
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Domperidone
  • Sponsor:Centre Hospitalier Universitaire Rouen
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Colchicine
  • Sponsor:Assistance Publique Hopitaux De Paris
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Amikacin
  • Sponsor:Centre Hospitalier Universitaire Amiens Picardie
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Abatacept
  • Sponsor:Les Hopitaux Universitaires De Strasbourg
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Centre Hospitalier Universitaire Amiens Picardie
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.